IL17A (Secukinumab Biosimilar) anticorps

N° du produit ABIN7490998

Détail du produit anti-IL17A (Secukinumab Biosimilar) anticorps

Antigène: IL17A (Secukinumab Biosimilar)

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp IL17A (Secukinumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS)

Fonction: Anti-IL17A (Secukinumab biosimilar) mAb

Attributs du produit: AIN457

Purification: Purified from cell culture supernatant by affinity chromatography

Classe de qualité: Research Grade

Isotype: IgG1

Information d'application

Indications d'application: Flow Cyt  1:100

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur IL17A (Secukinumab Biosimilar)

Antigène: IL17A (Secukinumab Biosimilar)

Abstract: IL17A (Secukinumab Biosimilar) Produits

Classe de substances: Biosimilar

Sujet: CTLA-8,CTLA8,IL-17,IL-17A,IL17

UniProt: Q16552